Showing results (301-310 of 333) with videos related to

Sort By:
Pageof 34
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 11, 2000
Wild-type huntingtin protects from apoptosis upstream of caspase-3D Rigamonti, J H Bauer, C De-Fraja, et al.
Clinical Genetics|April 29, 1998
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study GroupJ J Kastelein, B E Groenemeyer, D M Hallman, et al.
The Journal of Biological Chemistry|March 20, 1999
Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicityL M Ellerby, R L Andrusiak, C L Wellington, et al.
Nature Genetics|May 1, 1997
HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brainM A Kalchman, H B Koide, K McCutcheon, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 6, 2025
Reduced Palmitoylation of SQSTM1/p62 in Huntington Disease Is Associated With Impaired AutophagyF Abrar, M C Davies, Y Alshehabi, et al.
Circulation|October 15, 1996
The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin StudyJ W Jukema, A J van Boven, B Groenemeijer, et al.
The Pharmacogenomics Journal|January 19, 2011
Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatinL R Brunham, P J Lansberg, L Zhang, et al.
Clinical Genetics|May 25, 2013
Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in familiesA E Bochem, J C van Capelleveen, G M Dallinga-Thie, et al.
European Journal of Clinical Investigation|March 27, 1999
Lipid and lipoprotein analysis of cats with lipoprotein lipase deficiencyD G Ginzinger, S M Clee, J Dallongeville, et al.
The Pharmacogenomics Journal|April 17, 2013
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descentF Aminkeng, C J D Ross, S R Rassekh, et al.
Pageof 34